These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 1834345)

  • 1. In vitro and in vivo immunosuppressive effects of supernatants from human choriocarcinoma cell lines.
    Krishnan L; Menu E; Chaouat G; Talwar GP; Raghupathy R
    Cell Immunol; 1991 Dec; 138(2):313-25. PubMed ID: 1834345
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biological activity of the suppressor cells inducer factor secreted by the Jeg-3 choriocarcinoma cell line.
    Markert UR; Chaouat G
    Am J Reprod Immunol; 2001 Nov; 46(5):332-41. PubMed ID: 11712762
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suppression of local and systemic GVHR by supernatants from human choriocarcinoma cell lines.
    Krishnan L; Kinsky R; Chaouat G; Talwar GP; Raghupathy R
    Cell Immunol; 1993 Sep; 150(2):376-81. PubMed ID: 8370079
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preliminary characterization of an immunosuppressive inducer factor secreted by the JEG-3 choriocarcinoma cell line: in vitro and in vivo studies.
    Markert UR; Chaouat G
    Am J Reprod Immunol; 1997 Nov; 38(5):327-38. PubMed ID: 9352024
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Immunosuppressive substance derived from choriocarcinoma (author's transl)].
    Tsuji Y
    Nihon Sanka Fujinka Gakkai Zasshi; 1980 May; 32(5):627-34. PubMed ID: 6453912
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The immunosuppression of human T cell proliferation pathways by a choriocarcinoma-cell-derived factor.
    Matsuzaki N; Okada T; Hirota K; Kameda T; Negoro T; Saji F; Tanizawa O
    Nihon Sanka Fujinka Gakkai Zasshi; 1988 Jun; 40(6):799-800. PubMed ID: 3260613
    [No Abstract]   [Full Text] [Related]  

  • 7. Characterization of an immunosuppressive factor secreted by a human trophoblast-derived choriocarcinoma cell line.
    Krishnan L; Sad S; Raghupathy R
    Cell Immunol; 1995 May; 162(2):295-308. PubMed ID: 7743558
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The analysis of immunosuppressive substance derived from choriocarcinoma cell lines].
    Matsuzaki N
    Nihon Sanka Fujinka Gakkai Zasshi; 1983 Apr; 35(4):481-8. PubMed ID: 6222124
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Humoral and cellular immunity to paternal antigens in trophoblastic neoplasia.
    Shaw AR; Dasgupta MK; Kovithavongs T; Johny KV; leRiche JC; Dossetor JB; McPherson TA
    Int J Cancer; 1979 Nov; 24(5):586-93. PubMed ID: 231016
    [No Abstract]   [Full Text] [Related]  

  • 10. Trophoblast-derived immunoregulatory factor: demonstration of the biological function and the physicochemical characteristics of the factor derived from choriocarcinoma cell lines.
    Matsuzaki N; Okada T; Kameda T; Negoro T; Saji F; Tanizawa O
    Am J Reprod Immunol; 1989 Apr; 19(4):121-7. PubMed ID: 2669822
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interaction of choriocarcinoma cells and human peripheral blood lymphocytes. Resistance of cultured choriocarcinoma cells to cell-mediated cytotoxicity by mitogen-activated lymphocytes.
    August CS; Cox ST; Naughton MA
    J Clin Invest; 1979 Mar; 63(3):428-36. PubMed ID: 570981
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Immunological and hormono-metabolic indices in trophoblastic disease].
    Poroshina TE; Semenovskiĭ AV; Bobrov IuF; Gamaiunova VB; Ostroumova MN
    Vopr Onkol; 1987; 33(10):57-61. PubMed ID: 2825428
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [In vitro activity of HL-A antigens and lymphocytes in choriocarcinoma and hydatidiform mole pregnancy].
    Tamás K; Gabriella K; Ildikó P; László K
    Orv Hetil; 1976 Oct; 117(41):2478-80. PubMed ID: 135239
    [No Abstract]   [Full Text] [Related]  

  • 14. Choriocarcinoma-induced suppression of lymphocyte activity.
    Markert UR; Kilic M; Schleussner E; Vogelsang H
    J Investig Allergol Clin Immunol; 2000; 10(6):323-6. PubMed ID: 11206931
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gamma-interferon enhances expression of Class I MHC antigens in the weakly HLA+ human choriocarcinoma cell line BeWo, but does not induce MHC expression in the HLA- choriocarcinoma cell line Jar.
    Anderson DJ; Berkowitz RS
    J Immunol; 1985 Oct; 135(4):2498-501. PubMed ID: 3928751
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Cellular immunity in uterine trophoblastic tumors].
    Veskova TK; Artamonova SI; Stas TA
    Akush Ginekol (Mosk); 1980 Jun; (6):16-8. PubMed ID: 6250418
    [No Abstract]   [Full Text] [Related]  

  • 17. Immunosuppression in vitro and in vivo by supernatants from murine lymphoma cell lines.
    Klajman A; Drucker I; Zan-Bar I; Mekori Y; Ben-Efraim S
    Anticancer Res; 1992; 12(3):741-7. PubMed ID: 1535768
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SALL4 expression in gestational trophoblastic tumors: a useful tool to distinguish choriocarcinoma from placental site trophoblastic tumor and epithelioid trophoblastic tumor.
    Stichelbout M; Devisme L; Franquet-Ansart H; Massardier J; Vinatier D; Renaud F; Kerdraon O
    Hum Pathol; 2016 Aug; 54():121-6. PubMed ID: 27068524
    [TBL] [Abstract][Full Text] [Related]  

  • 19. JEG-3 cell culture supernatants cause reduced interferon-gamma and interleukin-17 production in mixed-lymphocyte reactions.
    Pongcharoen S; Niumsup PR; Sanguansermsri D
    Am J Reprod Immunol; 2007 Mar; 57(3):227-31. PubMed ID: 17295902
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of placental growth hormone variant and chorionic somatomammotropin ribonucleic acid expression in human trophoblastic neoplasms by reverse transcriptase-polymerase chain reaction.
    Lytras A; Bock ME; Dodd JG; Cattini PA
    Endocrinology; 1994 Jun; 134(6):2461-7. PubMed ID: 7515000
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.